Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-03-13 00:00:00 ET · period of report 2024-03-12 · accession 0001127602-24-009989 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-13 | 2024-03-12 | TMO | Britt Lisa P. | SVP, Chief HR Off | S - Sale+OE | $598.90 | -14.3K | 17.3K | -45% | -$8.59M |
| DM | 2024-03-13 | 2024-03-12 | TMO | Britt Lisa P. | SVP, Chief HR Off | M - OptEx | $198.85 | +14.3K | 25.8K | +126% | +$2.85M |
| DM | 2024-03-13 | 2024-03-12 | TMO | Britt Lisa P. | SVP, Chief HR Off | M - OptEx | $0.00 | -14.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-12 | S | D | 8,445 | $598.90 | 17,323.11 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-12 | M | A | 5,900 | $210.68 | 23,223.11 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-12 | M | A | 8,445 | $190.59 | 25,768.11 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-12 | S | D | 5,900 | $598.90 | 17,323.11 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-03-12 | M | D | 8,445 | $0.00 | 0 | D | $190.59 · 2021-03-07 to 2024-09-07 | 8,445 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-03-12 | M | D | 5,900 | $0.00 | 0 | D | $210.68 · — to 2025-02-27 | 5,900 Common Stock | (F2) The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022. |